All 1 tracked stories fall under one category: pharma. Anhui Agricultural University is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 5 original sources on average. We currently track 1 Biotech story that mention Muhammad Jalal, all published on March 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Muhammad Jalal
All 1 tracked stories fall under one category: pharma. Anhui Agricultural University is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 5 original sources on average. We currently track 1 Biotech story that mention Muhammad Jalal, all published on March 13, 2026.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Muhammad Jalal. Shared-story counts are live from our verified record — not editorial picks.
Muhammad Jalal, a Pakistani researcher at Anhui Agricultural University, exemplifies the growing scientific collaboration between China and Pakistan. This trend highlights China's emergence as a global biotech R&D hub and its strategic efforts to cultivate international talent through the Belt and Road Initiative.